Cargando…
Safety and Observations from a Placebo‐Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism
The aim of this exploratory study was to assess the safety and clinical effects of autologous umbilical cord blood (AUCB) infusion in children with idiopathic autism spectrum disorder (ASD). Twenty‐nine children 2 to 6 years of age with a confirmed diagnosis of ASD participated in this randomized, b...
Autores principales: | Chez, Michael, Lepage, Christopher, Parise, Carol, Dang‐Chu, Ashley, Hankins, Andrea, Carroll, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866927/ https://www.ncbi.nlm.nih.gov/pubmed/29405603 http://dx.doi.org/10.1002/sctm.17-0042 |
Ejemplares similares
-
Electrophysiological Biomarkers Predict Clinical Improvement in an Open‐Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism
por: Murias, Michael, et al.
Publicado: (2018) -
Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism
por: Chez, Michael, et al.
Publicado: (2012) -
Umbilical Cord Blood Therapy Potentiated with Erythropoietin for Children with Cerebral Palsy: A Double-blind, Randomized, Placebo-Controlled Trial
por: Min, Kyunghoon, et al.
Publicado: (2013) -
Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single‐Center Phase I Open‐Label Trial
por: Dawson, Geraldine, et al.
Publicado: (2017) -
Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape
por: Dessels, Carla, et al.
Publicado: (2018)